The baker's yeast, Saccharomyces cerevisiae, is also capable of undergoing programmed cell death or apoptosis, for example in response to viral infection as well as during chronological and replicative aging. Intrinsically, programmed cell death in yeast can be induced by, for example, H 2 O 2 , acetic acid or the matingtype pheromone. A number of evolutionarily conserved apoptosis-regulatory proteins have been identified in yeast, one of which is the HtrA (high-temperature requirement A)-like serine protease Nma111p (Nma is nuclear mediator of apoptosis). Nma111p is a nuclear serine protease of the HtrA family, which targets Bir1p, the only known inhibitor-of-apoptosis protein in yeast. Nma111p mediates apoptosis in a serine-proteasedependent manner and exhibits its activity exclusively in the nucleus. How the activity of Nma111p is regulated has remained largely elusive, but some evidence points to a control by phosphorylation. Current knowledge of Nma111p's function in apoptosis will be discussed in the present review.
Introduction
HtrA (high-temperature requirement A) proteases were first described in Escherichia coli as heat-shock-induced serine proteases [1, 2] and are widely conserved in almost all bacterial and eukaryotic genomes [3, 4] . A defining feature of the HtrA protein family is the combination of a catalytic serine protease domain with one or two PDZ domains [3, 5, 6] . PDZ domains are small globular protein-protein interaction modules involved in many signalling pathways [3, 4, 6] . Consequently, HtrA proteases are implicated in many important cellular processes and dysfunction of mammalian HtrAs is correlated with severe diseases, for example Parkinson's and Alzheimer's diseases, myocardial ischaemia and cancer [7] [8] [9] [10] .
Saccharomyces cerevisiae encodes one HtrA-like protein called Nma111p (also called Ynm3p; Nma is nuclear mediator of apoptosis). Nma111p harbours an internal duplication of the HtrA-like sequence with the N-terminal repeat retaining the catalytic triad residues of HtrA-like serine proteases ( Figure 1) [3, 5, 11] . In contrast, the C-terminal repeat contains an incomplete serine protease site that is supposed to be non-functional. Nma111p is able to promote apoptotic cell death in S. cerevisiae [12] , similarly to its recently identified homologue BcNma of the grey mould Botrytis cinerea [13] as well as its closest metazoan homologues, human and Drosophila Omi/HtrA2 [7, [14] [15] [16] [17] [18] [19] . In addition, Nma111p is implicated in lipid homoeostasis and exhibits chaperone activity [20, 21] . Current knowledge of Nma111p's function in apoptosis will be summarized in this paper.
Nma111p facilitates apoptosis in yeast
Nma111p was identified due to its two-hybrid interaction with a yeast nuclear pore protein [12] . It localizes to the nucleus, in contrast with Omi/HtrA2, which localizes to mitochondria in metazoa [15, 17, 19, 22] . Yeast cells that lack Nma111p survive better at elevated temperatures and the cells show no apoptotic hallmarks, such as chromatin condensation or accumulation of reactive oxygen species, after treatment with H 2 O 2 , a known trigger of apoptosis in yeast [12] . Overexpression of Nma111p, in contrast, promotes apoptotic cell death in yeast and this activity is dependent on the integrity of its serine protease domain. A mutation of Ser 235 to cysteine (S235C) significantly reduces Nma111p's pro-apoptotic properties as compared with the wild-type protein. Somewhat controversially, however, the chaperone activity of Nma111p appears to depend on Ser 236 [20] .
Omi/HtrA2 promotes apoptosis by binding and degrading cellular IAPs (inhibitor of apoptosis proteins) [15, 19, [22] [23] [24] [25] [26] . IAPs are characterized by the presence of BIR (baculovirus IAP repeat) domains [27] and the yeast genome harbours only one BIR protein called Bir1p. Bir1p was known for its role as chromosomal passenger protein [28] [29] [30] and turned out to be a substrate for Nma111p and a bona fide IAP in S. cerevisiae [31] . Degradation of Bir1p occurs in yeast cells overexpressing intact Nma111p, but not in cells expressing an S235C mutant of Nma111p. In vitro, recombinantly expressed Bir1p physically interacts with fulllength Nma111p and the N-terminal HtrA repeat, but not with the C-terminal HtrA repeat of Nma111p [31] . The molecular mechanism underlying how Bir1p degradation by Nma111p promotes yeast cell death has, however, remained elusive.
Figure 1 Schematic representation of the domain organization of Nma111p

Nma111p acts in the cell nucleus
Nma111p is a nuclear protein under steady-state conditions, as is Bir1p, which indicates that some of the processes that occur in the cytoplasm during mammalian apoptosis may take place in the yeast nucleus. Alternatively, Nma111p (and other apoptotic regulatory factors) might translocate from the nucleus to the cytoplasm under apoptotic conditions to exert its function. Therefore it was important to determine whether Nma111p in fact is an exclusively nuclear protein or whether changes in nuclear localization are important for its function in response to oxidative stress (i.e. H 2 O 2 treatment) and/or during chronological aging, a physiological cell death scenario in yeast. By employing a heterokaryon assay, Belanger et al. [32] could show that Nma111p is not capable of shuttling between the nucleus and the cytoplasm and that it remains nuclear under steady-state conditions in the absence or presence of H 2 O 2 to induce apoptosis. The nuclear localization of Nma111p is due to a bipartite basic NLS (nuclear localization signal) within the first 35 amino acids of the protein (Figure 1 ). This NLS sequence is recognized by the nuclear import receptor Kap95p, which appears to be the major, but not exclusive, nuclear import receptor for Nma111p [32] . Importantly, disruption of any of the two stretches of the NLS affects the ability of Nma111p to promote cell death in response to oxidative stress and during chronological aging. Furthermore, it is the N-terminal HtrA repeat of Nma111p that is sufficient and essential to induce apoptosis in both cell death scenarios. This N-terminal HtrA repeat harbours the NLS and the intact serine protease domain. Therefore yeast cells expressing the N-terminal HtrA repeat of Nma111p with an S235C mutation or only the C-terminal HtrA repeat are protected against cell death, similarly to Δnma cells, but in contrast with wild-type yeast cells or cells expressing the N-terminal HtrA repeat [32] .
Conclusion
The HtrA-like serine protease Nma111p is a nuclear protein and is able to facilitate cell death in yeast. The pro-apoptotic activity of Nma111p depends on its serine protease activity, its nuclear localization and its N-terminal HtrA repeat. Nma111p exerts its function in part by degrading the only S. cerevisiae IAP, Bir1p. How the activity of Nma111p is regulated has remained elusive, but preliminary data indicate that phosphorylation may play a role. Nma111p is phosphorylated at Ser 993 ( Figure 1 ) (http://yeastgenome.org) and the phosphoylation levels of Nma111p appear to be reduced under apoptotic conditions, which coincides with enhanced Bir1p degradation (J. Jüttner, E. Owsianowski and B. Fahrenkrog, unpublished work). The expressions of phospho mutants and phosphomimetic mutants of Nma111p in yeast cells alter its pro-apoptotic activity, but have a different impact in response to oxidative stress and during chronological aging respectively (A. Gheeraert and B. Fahrenkrog, unpublished work). Therefore the regulation of Nma111p's activity appears to be quite complex and further studies are required in order to address this issue more systematically.
Funding
This work was supported by a Mobilité Ulysse grant [grant number F.6006.10] from the Fonds de la Recherche Scientifique, Belgium, as well as by the Université Libre de Bruxelles.
